Abstract:OBJECTIVE To investigate the relationship between alterations of p16INK4a and p14ARF genes and gastric carcinogenesis. METHODS Tumors and gastric tissues neighboring carcinoma from 48 patients with gastric cancer were studied. Homozygous deletion, mutation, methylation of the CpG islands, mRNA expression of p16INK4a and p14ARF genes were assessed by polymerase chain reaction (PCR), PCR-single strand conformation polymorphism (SSCP), PCR based methylation assay, and reverse transcription (RT)-PCR. RESULTS (1) The overall homozygous deletion rate of p16INK4a and p14ARF was 35.4% (17/48), and no homozygous deletion was examined in all the gastric tissues neighboring tumor. (2) There was no point mutation of p16INK4a and p14ARF in 31 gastric cancers without homozygous deletion and in the matched gastric tissues adjacent to tumor. (3) Methylation of the CpG islands of p16INK4a and p14ARF was detected in 47.9% (23/48) of gastric cancers, while methylation was observed only in 2 of 48 gastric tissues neighboring cancers with a significant difference (P <0.01). (4) The rate of p16INK4a mRNA loss was 47.9% (23/48) in gastric cancer, and the cases of combined methylation of exons 1alpha and 2 had a higher loss rate (100%, 6/6) of p16INK4a mRNA than those of methylation form the other exons (11.8%, 2/17) (P <0.01). The loss rate of p14ARF mRNA was 45.8% (22/48) in gastric cancer, and patients with combined methylation of exons 1beta and 2 had a higher loss rate (100%, 3/3) of p14ARF mRNA than those of the methylation from the other exons (15%, 3/20) (P < 0.05). (5) The combined loss of p16INK4a and p14ARF mRNAs was examined in 1 (5.6%) of 18 cases of well and moderately-differentiated carcinomas, and 11 (36.7%) of 30 cases of poorly and not-differentiated carcinomas with significant difference (P <0.05). CONCLUSION p16INK4a and p14ARF genes were frequently inactivated by homozygous deletion and methylation of the 5' CpG islands in gastric cancer, which might have played an important role in the development of gastric cancer.

Deletion of RDINK4/ARF enhancer: A novel mutation to “inactivate” the INK4-ARF locus

Progress in the Tumor Suppressor, ARF

ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2

The ARF tumor suppressor: Structure, functions and status in cancer

Simultaneous Loss of P14arf and P16ink4a Expression in Lung Cancer Cells and Its Significance

Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

Oncogenes & Tumor Suppressors ARF Regulates the Stability of p 16 Protein Via REG g-Dependent Proteasome Degradation

Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15INK4B tumor suppressor gene

INK4a/ARF limits the expansion of cells suffering from replication stress

ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation.

P14ARF: The Absence that Makes the Difference

Data from ARF Regulates the Stability of p16 Protein Via REGγ-Dependent Proteasome Degradation

Methylation and Demethylation of Ink4 Locus in Cancer Development

Proliferative and Invasive Effects of Inhibitors of Kinase 4 (p15ink4b and P16ink4a/CDKN2) Gene Activation on RKO Human Colorectal Cancer Cells

Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis

Role of Ink4a/Arf Locus in Beta Cell Mass Expansion under Physiological and Pathological Conditions

Relationship Between Alterations of P16ink4a and P14arf Genes of CDKN2A Locus and Gastric Carcinogenesis

The Influence of INK4 Proteins on Growth and Self-Renewal Kinetics of Hematopoietic Progenitor Cells.

Activated K‐Ras and INK4a/Arf Deficiency Promote Aggressiveness of Pancreatic Cancer by Induction of EMT Consistent with Cancer Stem Cell Phenotype

Characterization of a base-resolution common deletion region within CDKN2A gene in cancers and its biological and clinical significances

Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.